What was 3M's revenue in Q2 2026?

3M's revenue was $8.2 billion in Q2 2026, up 4% year-over-year.

Did 3M raise its full-year guidance?

Yes, 3M raised its 2026 guidance, now expecting EPS between $9.80 and $10.20.

What are the risks facing 3M's stock?

The main risk is pending litigation related to its products, which could impact cash flows.

How did 3M's stock perform after the earnings release?

The stock rose 2% in after-hours trading but later declined as litigation concerns resurfaced.

3M Beats Earnings Estimates for Fifth Straight Quarter, Raises Guidance

3M (MMM) reported Q2 2026 earnings beating analyst estimates for the fifth straight quarter, driven by growth in healthcare and safety segments. The company raised its full-year guidance, but lingering litigation risks and a divided analyst camp raise questions about the rally's sustainability.

3M (MMM) reported second-quarter 2026 results that exceeded analyst expectations for the fifth consecutive quarter, driven by strong demand in healthcare and industrial safety. The company also raised its full-year guidance, but the stock saw mixed reactions amid ongoing litigation concerns.

Key Financial Results

Metric	Q2 2026	Q2 2025	Change
Revenue	$8.2B	$7.9B	+4%
Net Income	$1.5B	$1.3B	+15%
EPS	$2.45	$2.20	+11%

Highlights from the Report

3M attributed the strong performance to improved demand in end markets, particularly healthcare and industrial safety. Cost-cutting measures also contributed to margin expansion.

Forward Guidance

The company raised its full-year 2026 guidance, now expecting revenue growth of 3% to 5% and EPS in the range of $9.80 to $10.20, up from the previous forecast of $9.50 to $9.90.

Impact on the Stock

Shares of 3M rose 2% in after-hours trading but later gave back gains as litigation risks resurfaced. Analysts remain divided, with some bullish on the earnings momentum and others cautious due to legal overhangs.

What This Means for Investors

3M continues to demonstrate strong earnings power and a solid dividend track record. However, investors should monitor the progress of litigation cases, which could impact future cash flows. A balanced approach considering both upside and downside risks is recommended.